Screen and verification of serum diagnostic markers for syncope

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037041

Enrollment

Unknown

Registered

2020-08-26

Start date

2020-08-26

Completion date

Unknown

Last updated

2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Syncope

Interventions

Gold Standard:Symptoms of syncope appear, exclude non-synchronous loss of consciousness,and Various examinations, such as ECG monitoring, cardiac electrophysiological examination, cardiac ultrasound,

Index test:serum&#32

diagnostic&#32

markers&#32

for&#32

syncope

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: All causes of syncope in patients.

Exclusion criteria

Exclusion criteria: Patients with a final diagnosis of non-synchronic loss of consciousness (e.g., epilepsy, falls, alcoholism) were excluded.

Design outcomes

Primary

Measure	Time frame
Serum proteins and metabolites;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactXie Yucai

Ruijin Hospital affiliated to Shanghai Jiao Tong University Medical College

drxieyucai@163.com+86 18017881566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026